Loading company…
Valhalla Tech develops AI models and molecular design systems for biological research and drug discovery.
Founded in 2026, Valhalla Tech develops AI4Bio and molecular design technologies, including the AlloDesign system and work on cyclic peptide design. Its initial application area is drug discovery. The company is based in Zhejiang, China. In July 2026, it raised nearly USD 50 million from 5Y Capital, ZhenFund, Casstar Capital, Xiang He Capital, Shanghai Growth Investment, Landstone Capital, MiraclePlus, Lighthouse Capital, and other investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in